Glimepiride
Product Images NDC 70934-232

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 70934-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 232 30 Rev A 01 19)

Label (70934 232 30   Rev A 01 19)
This is a package of Glimepiride Tablets, USP of 2mg strength. The tablets come in a container of 30 pieces, and the dosage information is available in the package insert. The tablets contain Glimepiride, USP of 2mg strength. The recommended storage temperature is 25°C (77°F) with permitted excursions to 20°:25%C (68°77°F). The package warns that it must be kept out of the reach of children and stored in the original container. The medicine was manufactured by Accord Healthcare, Inc., North Blenheim, NY, and has an expiration date of 00/00/0000. Lot number 0000000000 is marked on the package. There are additional texts containing distorted information and may be invalid.*
FDA Label Image

Structure (Glimepiride Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.